Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents. Background: To evaluate the efficacy and E2,LH,FSH level of goserelin combined with CEF chemotherapy as neoadjuvant therapy in hormone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback